Celgene Corp (CELG) 120.08 $CELG
Look for Shares of Celgene to Potentially Pullback after Yesterday's 2.40% Rise
Comtex SmarTrend(R) - 1 hr 47 mins ago
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.35 to a high of $120.90. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $120.51 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 120.08 (+2.82)
Agios (AGIO) Provides Pipeline Update, AG-221 in Focus
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 3:40PM CDT
Agios Pharmaceuticals (AGIO) announced its pipeline development strategy for its lead cancer metabolism and rare genetic metabolic disorders programs at its R&D Day.
AZN: 31.36 (+0.29), AGIO: 61.72 (+0.24), CELG: 120.08 (+2.82)
'Mad Money' Lightning Round: Take Union Pacific Over Kansas City Southern
at The Street - Thu Oct 22, 5:00AM CDT
Cramer is avoiding Chesapeake Energy and Micron Technology and says wait on Lions Gate Entertainment.
MU: 17.24 (+0.52), CRC: 4.05 (-0.04), S: 4.71 (+0.25), LGF: 38.66 (+0.20), CHK: 7.83 (+0.03), KSU: 86.13 (-0.02), AMAG: 37.85 (+4.24), TSN: 47.44 (+0.26), TMUS: 41.27 (+0.83), OXY: 73.71 (-0.63), VZ: 46.16 (+0.27), UNP: 96.92 (-0.09), CELG: 120.08 (+2.82)
Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide
at The Street - Wed Oct 21, 6:50PM CDT
Some days you get mauled in the market, other days you might not, says Cramer.
GE: 29.51 (-0.07), CLX: 123.25 (-0.35), HON: 103.13 (+0.55), UTX: 100.62 (+0.83), KSU: 86.13 (-0.02), KMB: 121.24 (+0.44), SLB: 78.35 (+0.09), SAP: 77.32 (+0.30), LGF: 38.66 (+0.20), CHK: 7.83 (+0.03), S: 4.71 (+0.25), CMG: 649.72 (-0.90), AMAG: 37.85 (+4.24), TMUS: 41.27 (+0.83), TWTR: 30.28 (+1.13), UNP: 96.92 (-0.09), MU: 17.24 (+0.52), TSN: 47.44 (+0.26), WDC: 69.34 (-0.62), BA: 146.70 (+0.39), TUP: 60.00 (-1.27), CELG: 120.08 (+2.82), CRC: 4.05 (-0.04), TXN: 58.98 (+0.89), GM: 35.95 (+0.53), RACE: 56.38 (-0.37), VZ: 46.16 (+0.27), SNDK: 78.37 (+1.28)
Battle Royale: Gilead Sciences Inc vs Celgene Corporation
Brian Feroldi, The Motley Fool - Motley Fool - Wed Oct 21, 2:09PM CDT
Photo by Mattza / Flickr creative Commons It's been a rough couple of months to be a biotech focused investor. Since peaking in price over the summer, biotech stocks on the whole have basically been in free-fall. The iShares Nasdaq Biotechnology...
GILD: 107.99 (+0.39), CELG: 120.08 (+2.82)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 276.99 (+0.16), TSLA: 209.09 (-2.63), VRX: 116.16 (+6.29), KMB: 121.24 (+0.44), IBB: 316.28 (+10.17), SBUX: 62.61 (+1.12), YHOO: 33.17 (+1.50), CMG: 649.72 (-0.90), ABBV: 50.34 (+2.07), GOOGL: 719.33 (+38.19), AAPL: 119.08 (+3.58), KO: 42.79 (-0.45), AMZN: 599.03 (+35.12), MU: 17.24 (+0.52), PFE: 34.05 (+0.72), FCAU: 15.37 (+0.13), BA: 146.70 (+0.39), WDC: 69.34 (-0.62), CELG: 120.08 (+2.82), GILD: 107.99 (+0.39), LRCX: 74.57 (+1.96), GM: 35.95 (+0.53), MCD: 112.59 (+1.72), KLAC: 65.35 (+0.45), RACE: 56.38 (-0.37), SNDK: 78.37 (+1.28)
Stock Market News for October 21, 2015
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 9:10AM CDT
Benchmarks ended in the red on Tuesday, dragged down by declines in biotech and healthcare stocks
BIIB: 276.99 (+0.16), HOG: 48.20 (+0.09), IBM: 144.68 (+0.59), GILD: 107.99 (+0.39), UTX: 100.62 (+0.83), PFE: 34.05 (+0.72), MRK: 52.88 (+0.87), AMGN: 155.75 (+3.44), VZ: 46.16 (+0.27), REGN: 536.70 (+11.59), TRV: 112.28 (-0.04), CELG: 120.08 (+2.82)
Rotation Is Enough to Make Your Head Spin
at The Street - Tue Oct 20, 1:17PM CDT
Bad news isn't always a bad thing.
AMZN: 599.03 (+35.12), TSLA: 209.09 (-2.63), VRX: 116.16 (+6.29), HOG: 48.20 (+0.09), LMT: 219.32 (+2.81), ETN: 54.31 (-0.04), CLX: 123.25 (-0.35), UTX: 100.62 (+0.83), DAL: 51.00 (+0.19), CELG: 120.08 (+2.82), AGN: 268.55 (+15.51), GILD: 107.99 (+0.39), IBM: 144.68 (+0.59), GOOGL: 719.33 (+38.19), DOV: 64.44 (+0.44), PG: 77.03 (+2.18), PPG: 103.99 (+0.37), REGN: 536.70 (+11.59)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 1.30% Gain
Comtex SmarTrend(R) - Mon Oct 19, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $116.66 to a high of $120.27. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $118.64 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 120.08 (+2.82)
Stocks Deserve a Second Look as Rally Remains Intact
at The Street - Mon Oct 19, 1:42PM CDT
The CNBC 'Fast Money' traders are becoming more content with the legitimacy of the current rally. Apple and Nike are also discussed.
AMZN: 599.03 (+35.12), NKE: 130.53 (-1.88), FB: 102.19 (+2.52), GOOG: 702.00 (+50.21), MS: 32.62 (+0.27), CELG: 120.08 (+2.82), LEN: 52.12 (+0.28), BBBY: 59.21 (+0.52), SPY: 207.51 (+2.25), EBAY: 28.16 (+0.58), GOOGL: 719.33 (+38.19), XLF: 24.14 (+0.26), AAPL: 119.08 (+3.58)
Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at ACG Plenary Session
Business Wire - Mon Oct 19, 7:00AM CDT
--Clinical response and mucosal healing also significantly improved with Ozanimod 1 mg compared to placebo at week 32
CELG: 120.08 (+2.82)
Celgene names Julia A. Haller, MD to board
M2 - Mon Oct 19, 3:06AM CDT
Biopharmaceutical company Celgene Corporation (NasdaqGS:CELG) revealed on Friday the addition of Julia A. Haller, MD to its board of directors.
CELG: 120.08 (+2.82), CELGZ: 1.62 (-0.07)
PEP, KMB, STX, IBM: Jim Cramer's Views
at The Street - Mon Oct 19, 12:00AM CDT
Jim Cramer shares his views on the chicken growth stocks and intra-sector rotations. Pepsico, Kimberly-Clark, Seagate Technology and IBM are among the stocks discussed here.
MU: 17.24 (+0.52), AMZN: 599.03 (+35.12), GE: 29.51 (-0.07), SWKS: 82.55 (+0.86), CLX: 123.25 (-0.35), STX: 41.15 (+1.91), KMB: 121.24 (+0.44), WMT: 58.30 (-0.60), LLY: 78.31 (+1.33), NXPI: 96.09 (-1.86), WDC: 69.34 (-0.62), INTC: 34.90 (+0.50), HPQ: 29.03 (+0.26), PEP: 102.43 (-0.65), CELG: 120.08 (+2.82), QRVO: 51.50 (+1.95), IBM: 144.68 (+0.59), KHC: 77.98 (-1.96), SNDK: 78.37 (+1.28), REGN: 536.70 (+11.59), AVGO: 129.58 (+4.24), CRM: 78.56 (+1.19)
3 Biotechs Growing Faster Than Apple
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Oct 18, 12:02PM CDT
Image source: picaidol via Pixabay. If I (Brian Feroldi here!) could rewind the clock a decade or so and invest in one growth stock, it would probably be Apple , as the iPhone maker's growth over the past 10 years has simply been astounding. The...
ALXN: 171.16 (+4.40), AAPL: 119.08 (+3.58), REGN: 536.70 (+11.59), CELG: 120.08 (+2.82)
3 Blue-Chip Biotech Stocks Worth Buying for the Long Haul
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sat Oct 17, 11:25AM CDT
Image source: NWABR Flickr Creative Commons. While the stock market in general has been sold off over the last few months, healthcare-related stocks have fallen much harder than the rest of the market. The Vanguard Health Care ETF , for example,...
BIIB: 276.99 (+0.16), AMGN: 155.75 (+3.44), VHT: 127.26 (+2.74), CELG: 120.08 (+2.82)
Investing Moves for a No-Growth World; ETF Distortion: Jim Cramer's Best Blogs
at The Street - Fri Oct 16, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he discusses the shift to higher-risk investing, and the outsize power of ETFs and futures in the market now.
BIIB: 276.99 (+0.16), BMRN: 104.14 (+2.54), DAL: 51.00 (+0.19), C: 53.64 (+1.13), WMT: 58.30 (-0.60), KKR: 17.79 (+0.40), PANW: 159.20 (-6.94), ADBE: 87.86 (-0.60), V: 77.07 (+0.65), DG: 65.75 (-1.20), GOOGL: 719.33 (+38.19), CAT: 71.75 (+0.87), MA: 99.79 (+1.77), REGN: 536.70 (+11.59), AMZN: 599.03 (+35.12), KR: 37.82 (-0.47), SWKS: 82.55 (+0.86), FB: 102.19 (+2.52), NXPI: 96.09 (-1.86), BA: 146.70 (+0.39), CELG: 120.08 (+2.82), NFLX: 100.04 (+2.72), HCA: 68.98 (+2.90), AA: 9.14 (+0.05), GS: 185.50 (+1.94), QRVO: 51.50 (+1.95), GILD: 107.99 (+0.39), RHT: 77.39 (+0.42), WDAY: 79.85 (-0.04), FDC: 16.26 (+0.25), AVGO: 129.58 (+4.24), BABA: 75.62 (+4.63), CRM: 78.56 (+1.19)
Anatomy of a Rally: Simpler Than You Think
at The Street - Fri Oct 16, 1:00PM CDT
Understanding why stocks act the way they do.
AMZN: 599.03 (+35.12), GE: 29.51 (-0.07), CLX: 123.25 (-0.35), KMB: 121.24 (+0.44), KHC: 77.98 (-1.96), WMT: 58.30 (-0.60), LLY: 78.31 (+1.33), REGN: 536.70 (+11.59), CRM: 78.56 (+1.19), CELG: 120.08 (+2.82), PEP: 102.43 (-0.65)
Look for Shares of Celgene to Potentially Pullback after Yesterday's 2.40% Rise
Comtex SmarTrend(R) - 1 hr 47 mins ago
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $117.35 to a high of $120.90. Yesterday, the shares gained 2.4%, which took the trading range above the 3-day high of $120.51 on volume of 4.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 120.08 (+2.82)
Agios (AGIO) Provides Pipeline Update, AG-221 in Focus
Zacks Equity Research - Zacks Investment Research - Thu Oct 22, 3:40PM CDT
Agios Pharmaceuticals (AGIO) announced its pipeline development strategy for its lead cancer metabolism and rare genetic metabolic disorders programs at its R&D Day.
AZN: 31.36 (+0.29), AGIO: 61.72 (+0.24), CELG: 120.08 (+2.82)
'Mad Money' Lightning Round: Take Union Pacific Over Kansas City Southern
at The Street - Thu Oct 22, 5:00AM CDT
Cramer is avoiding Chesapeake Energy and Micron Technology and says wait on Lions Gate Entertainment.
MU: 17.24 (+0.52), CRC: 4.05 (-0.04), S: 4.71 (+0.25), LGF: 38.66 (+0.20), CHK: 7.83 (+0.03), KSU: 86.13 (-0.02), AMAG: 37.85 (+4.24), TSN: 47.44 (+0.26), TMUS: 41.27 (+0.83), OXY: 73.71 (-0.63), VZ: 46.16 (+0.27), UNP: 96.92 (-0.09), CELG: 120.08 (+2.82)
Jim Cramer's 'Mad Money' Recap: Nowhere to Run, Nowhere to Hide
at The Street - Wed Oct 21, 6:50PM CDT
Some days you get mauled in the market, other days you might not, says Cramer.
GE: 29.51 (-0.07), CLX: 123.25 (-0.35), HON: 103.13 (+0.55), UTX: 100.62 (+0.83), KSU: 86.13 (-0.02), KMB: 121.24 (+0.44), SLB: 78.35 (+0.09), SAP: 77.32 (+0.30), LGF: 38.66 (+0.20), CHK: 7.83 (+0.03), S: 4.71 (+0.25), CMG: 649.72 (-0.90), AMAG: 37.85 (+4.24), TMUS: 41.27 (+0.83), TWTR: 30.28 (+1.13), UNP: 96.92 (-0.09), MU: 17.24 (+0.52), TSN: 47.44 (+0.26), WDC: 69.34 (-0.62), BA: 146.70 (+0.39), TUP: 60.00 (-1.27), CELG: 120.08 (+2.82), CRC: 4.05 (-0.04), TXN: 58.98 (+0.89), GM: 35.95 (+0.53), RACE: 56.38 (-0.37), VZ: 46.16 (+0.27), SNDK: 78.37 (+1.28)
Battle Royale: Gilead Sciences Inc vs Celgene Corporation
Brian Feroldi, The Motley Fool - Motley Fool - Wed Oct 21, 2:09PM CDT
Photo by Mattza / Flickr creative Commons It's been a rough couple of months to be a biotech focused investor. Since peaking in price over the summer, biotech stocks on the whole have basically been in free-fall. The iShares Nasdaq Biotechnology...
GILD: 107.99 (+0.39), CELG: 120.08 (+2.82)
Stocks Turn Lower as Valeant Dents Biotech Sector
at The Street - Wed Oct 21, 9:41AM CDT
Stocks turn lower by mid-morning Wednesday as plummeting Valeant Pharmaceuticals shares pull the biotech sector to the downside.
BIIB: 276.99 (+0.16), TSLA: 209.09 (-2.63), VRX: 116.16 (+6.29), KMB: 121.24 (+0.44), IBB: 316.28 (+10.17), SBUX: 62.61 (+1.12), YHOO: 33.17 (+1.50), CMG: 649.72 (-0.90), ABBV: 50.34 (+2.07), GOOGL: 719.33 (+38.19), AAPL: 119.08 (+3.58), KO: 42.79 (-0.45), AMZN: 599.03 (+35.12), MU: 17.24 (+0.52), PFE: 34.05 (+0.72), FCAU: 15.37 (+0.13), BA: 146.70 (+0.39), WDC: 69.34 (-0.62), CELG: 120.08 (+2.82), GILD: 107.99 (+0.39), LRCX: 74.57 (+1.96), GM: 35.95 (+0.53), MCD: 112.59 (+1.72), KLAC: 65.35 (+0.45), RACE: 56.38 (-0.37), SNDK: 78.37 (+1.28)
Stock Market News for October 21, 2015
Zacks Equity Research - Zacks Investment Research - Wed Oct 21, 9:10AM CDT
Benchmarks ended in the red on Tuesday, dragged down by declines in biotech and healthcare stocks
BIIB: 276.99 (+0.16), HOG: 48.20 (+0.09), IBM: 144.68 (+0.59), GILD: 107.99 (+0.39), UTX: 100.62 (+0.83), PFE: 34.05 (+0.72), MRK: 52.88 (+0.87), AMGN: 155.75 (+3.44), VZ: 46.16 (+0.27), REGN: 536.70 (+11.59), TRV: 112.28 (-0.04), CELG: 120.08 (+2.82)
Rotation Is Enough to Make Your Head Spin
at The Street - Tue Oct 20, 1:17PM CDT
Bad news isn't always a bad thing.
AMZN: 599.03 (+35.12), TSLA: 209.09 (-2.63), VRX: 116.16 (+6.29), HOG: 48.20 (+0.09), LMT: 219.32 (+2.81), ETN: 54.31 (-0.04), CLX: 123.25 (-0.35), UTX: 100.62 (+0.83), DAL: 51.00 (+0.19), CELG: 120.08 (+2.82), AGN: 268.55 (+15.51), GILD: 107.99 (+0.39), IBM: 144.68 (+0.59), GOOGL: 719.33 (+38.19), DOV: 64.44 (+0.44), PG: 77.03 (+2.18), PPG: 103.99 (+0.37), REGN: 536.70 (+11.59)
SmarTrend Watching for Potential Pullback in Shares of Celgene After 1.30% Gain
Comtex SmarTrend(R) - Mon Oct 19, 3:53PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $116.66 to a high of $120.27. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $118.64 on volume of 4.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CELG: 120.08 (+2.82)
Stocks Deserve a Second Look as Rally Remains Intact
at The Street - Mon Oct 19, 1:42PM CDT
The CNBC 'Fast Money' traders are becoming more content with the legitimacy of the current rally. Apple and Nike are also discussed.
AMZN: 599.03 (+35.12), NKE: 130.53 (-1.88), FB: 102.19 (+2.52), GOOG: 702.00 (+50.21), MS: 32.62 (+0.27), CELG: 120.08 (+2.82), LEN: 52.12 (+0.28), BBBY: 59.21 (+0.52), SPY: 207.51 (+2.25), EBAY: 28.16 (+0.58), GOOGL: 719.33 (+38.19), XLF: 24.14 (+0.26), AAPL: 119.08 (+3.58)
Phase 2 Maintenance Data from Oral Ozanimod TOUCHSTONE Study in Ulcerative Colitis Presented at ACG Plenary Session
Business Wire - Mon Oct 19, 7:00AM CDT
--Clinical response and mucosal healing also significantly improved with Ozanimod 1 mg compared to placebo at week 32
CELG: 120.08 (+2.82)
Celgene names Julia A. Haller, MD to board
M2 - Mon Oct 19, 3:06AM CDT
Biopharmaceutical company Celgene Corporation (NasdaqGS:CELG) revealed on Friday the addition of Julia A. Haller, MD to its board of directors.
CELG: 120.08 (+2.82), CELGZ: 1.62 (-0.07)
PEP, KMB, STX, IBM: Jim Cramer's Views
at The Street - Mon Oct 19, 12:00AM CDT
Jim Cramer shares his views on the chicken growth stocks and intra-sector rotations. Pepsico, Kimberly-Clark, Seagate Technology and IBM are among the stocks discussed here.
MU: 17.24 (+0.52), AMZN: 599.03 (+35.12), GE: 29.51 (-0.07), SWKS: 82.55 (+0.86), CLX: 123.25 (-0.35), STX: 41.15 (+1.91), KMB: 121.24 (+0.44), WMT: 58.30 (-0.60), LLY: 78.31 (+1.33), NXPI: 96.09 (-1.86), WDC: 69.34 (-0.62), INTC: 34.90 (+0.50), HPQ: 29.03 (+0.26), PEP: 102.43 (-0.65), CELG: 120.08 (+2.82), QRVO: 51.50 (+1.95), IBM: 144.68 (+0.59), KHC: 77.98 (-1.96), SNDK: 78.37 (+1.28), REGN: 536.70 (+11.59), AVGO: 129.58 (+4.24), CRM: 78.56 (+1.19)
3 Biotechs Growing Faster Than Apple
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sun Oct 18, 12:02PM CDT
Image source: picaidol via Pixabay. If I (Brian Feroldi here!) could rewind the clock a decade or so and invest in one growth stock, it would probably be Apple , as the iPhone maker's growth over the past 10 years has simply been astounding. The...
ALXN: 171.16 (+4.40), AAPL: 119.08 (+3.58), REGN: 536.70 (+11.59), CELG: 120.08 (+2.82)
3 Blue-Chip Biotech Stocks Worth Buying for the Long Haul
Brian Feroldi, Todd Campbell, and George Budwell, The Motley Fool - Motley Fool - Sat Oct 17, 11:25AM CDT
Image source: NWABR Flickr Creative Commons. While the stock market in general has been sold off over the last few months, healthcare-related stocks have fallen much harder than the rest of the market. The Vanguard Health Care ETF , for example,...
BIIB: 276.99 (+0.16), AMGN: 155.75 (+3.44), VHT: 127.26 (+2.74), CELG: 120.08 (+2.82)
Investing Moves for a No-Growth World; ETF Distortion: Jim Cramer's Best Blogs
at The Street - Fri Oct 16, 8:00PM CDT
Catch up on Jim Cramer's ideas from this past week as he discusses the shift to higher-risk investing, and the outsize power of ETFs and futures in the market now.
BIIB: 276.99 (+0.16), BMRN: 104.14 (+2.54), DAL: 51.00 (+0.19), C: 53.64 (+1.13), WMT: 58.30 (-0.60), KKR: 17.79 (+0.40), PANW: 159.20 (-6.94), ADBE: 87.86 (-0.60), V: 77.07 (+0.65), DG: 65.75 (-1.20), GOOGL: 719.33 (+38.19), CAT: 71.75 (+0.87), MA: 99.79 (+1.77), REGN: 536.70 (+11.59), AMZN: 599.03 (+35.12), KR: 37.82 (-0.47), SWKS: 82.55 (+0.86), FB: 102.19 (+2.52), NXPI: 96.09 (-1.86), BA: 146.70 (+0.39), CELG: 120.08 (+2.82), NFLX: 100.04 (+2.72), HCA: 68.98 (+2.90), AA: 9.14 (+0.05), GS: 185.50 (+1.94), QRVO: 51.50 (+1.95), GILD: 107.99 (+0.39), RHT: 77.39 (+0.42), WDAY: 79.85 (-0.04), FDC: 16.26 (+0.25), AVGO: 129.58 (+4.24), BABA: 75.62 (+4.63), CRM: 78.56 (+1.19)
Anatomy of a Rally: Simpler Than You Think
at The Street - Fri Oct 16, 1:00PM CDT
Understanding why stocks act the way they do.
AMZN: 599.03 (+35.12), GE: 29.51 (-0.07), CLX: 123.25 (-0.35), KMB: 121.24 (+0.44), KHC: 77.98 (-1.96), WMT: 58.30 (-0.60), LLY: 78.31 (+1.33), REGN: 536.70 (+11.59), CRM: 78.56 (+1.19), CELG: 120.08 (+2.82), PEP: 102.43 (-0.65)
